Advertisement

Michael Diaz named president, managing physician of Florida Cancer Specialists and Research Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Michael Diaz was named president and managing physician at Florida Cancer Specialists and Research Institute. 

Diaz succeeds Lucio Gordan, who has held the position since 2018.

Diaz joined FCS in 2011 and provides care at two FCS office locations in St. Petersburg. Since November of 2018, he has worked as assistant managing physician for the statewide practice. Diaz serves on the FCS Executive Board and is the FCS director of patient advocacy. 

Advertisement

Gordan is a member of the board of directors for the Community Oncology Alliance and Florida Association of Clinical Oncology. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as chief medical officer of therapeutics and analytics for the statewide practice.

Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Advertisement
Advertisement